Literature DB >> 10617524

Regular review: treatment of Helicobacter pylori infection.

W A de Boer1, G N Tytgat.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 10617524      PMCID： PMC1117310          DOI： 10.1136/bmj.320.7226.31

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  23 in total

1.  Helicobacter pylori reinfection is virtually absent after successful eradication.

Authors:  R W van der Hulst; E A Rauws; B Köycü; J J Keller; F J ten Kate; J Dankert; G N Tytgat; A van der Ende
Journal:  J Infect Dis       Date:  1997-07       Impact factor: 5.226

2.  Testing for Helicobacter pylori infection after antibiotic treatment.

Authors:  P H Katelaris; D B Jones
Journal:  Am J Gastroenterol       Date:  1997-08       Impact factor: 10.864

3.  One-week triple therapy with omeprazole, amoxycillin and tinidazole for Helicobacter pylori infection: the significance of imidazole resistance.

Authors:  J C Thijs; A A Van Zwet; W J Thijs; E J Van der Wouden; A Kooy
Journal:  Aliment Pharmacol Ther       Date:  1997-04       Impact factor: 8.171

4.  One week triple therapy for Helicobacter pylori: a multicentre comparative study. Lansoprazole Helicobacter Study Group.

Authors:  J J Misiewicz; A W Harris; K D Bardhan; S Levi; C O'Morain; B T Cooper; G D Kerr; M F Dixon; H Langworthy; D Piper
Journal:  Gut       Date:  1997-12       Impact factor: 23.059

5.  How do clinicians practicing in the U.S. manage Helicobacter pylori-related gastrointestinal diseases? A comparison of primary care and specialist physicians.

Authors:  T Breuer; K J Goodman; H M Malaty; T Sudhop; D Y Graham
Journal:  Am J Gastroenterol       Date:  1998-04       Impact factor: 10.864

Review 6.  Clinical economics review: Helicobacter pylori-associated peptic ulcer disease.

Authors:  K Bodger; M J Daly; R V Heatley
Journal:  Aliment Pharmacol Ther       Date:  1997-04       Impact factor: 8.171

Review 7.  Treatment of Helicobacter pylori infection: a review of the world literature.

Authors:  R W van der Hulst; J J Keller; E A Rauws; G N Tytgat
Journal:  Helicobacter       Date:  1996-03       Impact factor: 5.753

8.  Metronidazole resistance reduces efficacy of triple therapy and leads to secondary clarithromycin resistance.

Authors:  M J Buckley; H X Xia; D M Hyde; C T Keane; C A O'Morain
Journal:  Dig Dis Sci       Date:  1997-10       Impact factor: 3.199

9.  The MACH2 study: role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies.

Authors:  T Lind; F Mégraud; P Unge; E Bayerdörffer; C O'morain; R Spiller; S Veldhuyzen Van Zanten; K D Bardhan; M Hellblom; M Wrangstadh; L Zeijlon; C Cederberg
Journal:  Gastroenterology       Date:  1999-02       Impact factor: 22.682

10.  Ranitidine bismuth citrate with clarithromycin versus omeprazole with amoxycillin in the cure of Helicobacter pylori infection.

Authors:  J J Kolkman; T G Tan; M Oudkerk Pool; W A Van Kleef; A A Geraedts; R J Timmerman; L F Crobach; J J Nicolai; A A Wolff; J Van Der Laan
Journal:  Aliment Pharmacol Ther       Date:  1997-12       Impact factor: 8.171
View more
  33 in total

1.  Treatment of Helicobacter pylori infection. Development of resistance to antibiotics used must be avoided.

Authors:  G G Rao; J O'Donohue; C S Mahankali Rao; H Fidler
Journal:  BMJ       Date:  2000-06-03

2.  Mutation frequency and biological cost of antibiotic resistance in Helicobacter pylori.

Authors:  B Björkholm; M Sjölund; P G Falk; O G Berg; L Engstrand; D I Andersson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

Review 3.  Treatment of Helicobacter pylori.

Authors:  A Harris
Journal:  World J Gastroenterol       Date:  2001-06       Impact factor: 5.742

4.  Second-line rescue therapy of helicobacter pylori infection.

Authors:  Javier P Gisbert
Journal:  Therap Adv Gastroenterol       Date:  2009-11       Impact factor: 4.409

5.  Development of a simple and rapid method based on polymerase chain reaction-based restriction fragment length polymorphism analysis to differentiate Helicobacter, Campylobacter, and Arcobacter species.

Authors:  A González; Y Moreno; R González; J Hernández; M A Ferrús
Journal:  Curr Microbiol       Date:  2006-10-19       Impact factor: 2.188

6.  One-week dual therapy with ranitidine bismuth citrate and clarithromycin for the treatment of Helicobacter pylori infection in Brazilian patients with peptic ulcer.

Authors:  Maria Aparecida Mesquita; Sonia Letícia Silva Lorena; Jazon Romilson Souza Almeida; Ciro Garcia Montes; Fábio Guerrazzi; Luciana T Campos; José Murilo Rubiota Zeitune
Journal:  World J Gastroenterol       Date:  2005-06-21       Impact factor: 5.742

Review 7.  "Rescue" regimens after Helicobacter pylori treatment failure.

Authors:  Javier P Gisbert
Journal:  World J Gastroenterol       Date:  2008-09-21       Impact factor: 5.742

Review 8.  Third-line rescue therapy for Helicobacter pylori infection.

Authors:  Rossella Cianci; Massimo Montalto; Franco Pandolfi; Giovan-Battista Gasbarrini; Giovanni Cammarota
Journal:  World J Gastroenterol       Date:  2006-04-21       Impact factor: 5.742

9.  Treatment of Helicobacter pylori Eradication Failures.

Authors:  Javier P. Gisbert; José María Pajares
Journal:  Curr Treat Options Gastroenterol       Date:  2003-04

10.  Short-term antibiotic treatment has differing long-term impacts on the human throat and gut microbiome.

Authors:  Hedvig E Jakobsson; Cecilia Jernberg; Anders F Andersson; Maria Sjölund-Karlsson; Janet K Jansson; Lars Engstrand
Journal:  PLoS One       Date:  2010-03-24       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.